Oramed Pharmaceuticals Inc. Made Big Gain
Fri 27 Nov 20 at 05:30 PM
Oramed Pharmaceuticals Inc. (ORMP:NASDAQ) shot up at $4.45, representing a gain of 37.8%. The stock got featured on our News Catalysts scanner on Tue 24 Nov 20 at 11:02 AM in the 'BIOTECH' category. From Wed 11 Nov 20, the stock recorded 60.00% Up Days and 54.55% Green Days
About Oramed Pharmaceuticals Inc. (ORMP:NASDAQ)
Oramed Pharmaceuticals Inc is a pharmaceutical company. The Company is engaged in the research and development of pharmaceutical solutions, including an orally ingestible insulin capsule or tablet.
Top 10 Gainers:
- SCWorx Corp. (WORX:NASDAQ), 77.6%
- Oramed Pharmaceuticals Inc. (ORMP:NASDAQ), 37.77%
- FreightCar America, Inc. (RAIL:NASDAQ), 37.31%
- ReneSola Ltd (SOL:NYSE), 33.1%
- Sundial Growers Inc. (SNDL:NASDAQ), 32.86%
- India Globalization Capital, Inc. (IGC:NYSEMKT), 30.14%
- Apex Technology Acquisition Corporation (APXT:NASDAQ), 29.21%
- NantKwest, Inc. (NK:NASDAQ), 28.25%
- FSTX (FSTX:NASDAQ), 27.78%
- Arcturus Therapeutics Holdings Inc. (ARCT:NASDAQ), 25.35%